Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

News in brief

David Jones, editor of the Royal Pharmaceutical Society’ (RPS) Journal of Pharmacy and Pharmacology (JPP)

David Jones, editor of the Journal of Pharmacy and Pharmacology, wins APS Innovative Science 2017 award Subscription

18 SEP 2017

David Jones, editor of the Royal Pharmaceutical Society (RPS) Journal of Pharmacy and Pharmacology (JPP) and pro-vice chancellor (Education and Students) at Queen’s University, Belfast, has received The Academy of Pharmaceutical Sciences (APS) Innovative Science 2017 award.[1]

antidepressant pills

Antidepressants linked to increased risk of mortality and new cardiovascular events

15 SEP 2017

Antidepressant use increases the risk of mortality and new cardiovascular events, according to a study published in Psychotherapy and Psychosomatics

newborn baby

Antibiotics should be offered to all women in pre-term labour

15 SEP 2017

All women who go into labour before 37 weeks of pregnancy should be offered antibiotics to prevent a potential transmission of Group B streptococcal disease to their babies, the Royal College of Obstetricians and Gynaecologists has said in revised guidelines.

Sepsis in the blood

Pharmacists to be trained on how to spot sepsis

15 SEP 2017

Pharmacists and care home staff are to be given additional training to spot signs of sepsis in patients, health secretary Jeremy Hunt has announced.

GP takes blood pressure of patient

STPs encouraged to involve pharmacies in coordinated drive to cut heart attacks and strokes

14 SEP 2017By

Public Health England and NHS England have launched a drive to improve detection and treatment of risk factors for cardiovascular disease, including more blood pressure testing and treatment in pharmacies and increasing update of NHS Health Checks.

EMA building

European Medicines Agency to host AMR summit

14 SEP 2017

The European Medicines Agency (EMA) is to host a summit meeting with doctors’ and patients’ organisations, academics, EU member states and the World Health Organization (WHO) to discuss how collaboration can help tackle antimicrobial resistance (AMR).

Atrial fibrillation ECG ss 17

Pharmacists screening for AF in hi-tech partnership

14 SEP 2017

Pharmacists are to use hand-held devices to test patients for atrial fibrillation (AF) as part of a hi-tech partnership in London.

steve brine cr carlton reid cc 17

Brine: Pharmacists play key role in reducing health inequalities

13 SEP 2017

Pharmacists have a key role to play in reducing health inequalities, Steve Brine told the Public Health England (PHE) annual conference.

Signage of the General Pharmaceutical Council (GPhC)

GPhC gives green light to updated training standards for pharmacy technicians

12 SEP 2017

The General Pharmaceutical Council has approved in principle updated standards for the initial education and training of pharmacy technicians.

Multiple myeloma cells ss 17

Ixazomib (Ninlaro) combination rejected for multiple myeloma in second draft guidance

12 SEP 2017

The National Institute for Health and Care Excellence (NICE) has again rejected ixazomib (Ninlaro) in combination with lenalidomide and dexamethasone (IRd) for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more previous therapies.

woman smoking ecigarette ss 17

E-cigarettes containing nicotine raise blood pressure and heart rate

12 SEP 2017

Users of e-cigarettes containing nicotine experience “significant” increased stiffening of the arteries, while blood pressure and heart rate also rise, according to the results of a Swedish study.

Non-small cell lung carcinoma NSCLC

Alectinib reduces CNS progression in NSCLC

8 SEP 2017

Data from two clinical trials have shown that second-generation ALK inhibitor alectinib (Alecensa, Roche) reduces central nervous system progression in ALK-positive non-small cell lung carcinoma.

MHRA head office

MHRA issues drug alert after drugs mislabelled

7 SEP 2017

Pharmacists have been warned to be aware of possible wrong labelling on a number of batches of drugs including medicines to treat epilepsy, anxiety and depression.

EMA building

EMA surveys pharmacists on their awareness of side-effect reporting

6 SEP 2017

The European Medicines Agency (EMA) has launched a survey for patients, pharmacists, doctors, nurses and other healthcare professionals to test their awareness of the arrangements for reporting drug reactions.

pembrolizumab ss sept17

Keytruda approved in Europe to treat metastatic urothelial cancer

6 SEP 2017

Pembrolizumab — marketed as Keytruda — has been given approval for use across Europe for some patients with a specific kind of bladder cancer, following a decision by the European Commission.

woman period pain ss 17

NICE publishes first guideline on endometriosis

6 SEP 2017

The National Institute for Health and Care Excellence’s guidance will help healthcare professionals reduce long waits between symptoms and diagnosis for women with the chronic condition.

david taylor 17

PHE publishes mental health resource

6 SEP 2017

Local resources to help support people to have better mental health have been produced, Public Health England (PHE) has announced.

US Food and Drug Administration (FDA) entrance building

FDA approves AML drug 17 years after initial approval

6 SEP 2017

The Food and Drug Administration has approved the use of gemtuzumab (Mylotarg) for the treatment of adults with acute myeloid leukaemia whose tumours express the CD33 antigen.

gino martini headshot

Royal Pharmaceutical Society appoints new chief scientist

3 SEP 2017

Royal Pharmaceutical Society announces new chief scientist, Gino Martini.

old man using laptop computer ss 17

Pharmacy2U criticised for confusing marketing tactics

1 SEP 2017

A National Pharmacy Association (NPA) survey found that pharmacists believe Pharmacy2U, Britain’s largest online pharmacy, has been sending out unsolicited marketing material that is confusing patients.

All News In Brief

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.